1.
|
Chung KF, Godard P, Adelroth E, et al:
Difficult/therapy-resistant asthma. Eur Respir J. 13:1198–1208.
1999.
|
2.
|
Targonski PV, Persky VW and Ramekrishnan
V: Effect of environmental molds on risk of death from asthma
during the pollen season. J Allergy Clin Immunol. 95:955–961. 1995.
View Article : Google Scholar : PubMed/NCBI
|
3.
|
Delfino RJ, Zeiger RS, Seltzer JM, Street
DH, Matteucci RM, Anderson PR and Koutrakis P: The effect of
outdoor fungal spore concentrations on daily asthma severity.
Environ Health Perspect. 105:622–635. 1997. View Article : Google Scholar : PubMed/NCBI
|
4.
|
Neas LM, Dockery DW, Burge H, Koutrakis P
and Speizer FE: Fungus spores, air pollutants and other
determinants of peak expiratory flow rate in children. Am J
Epidemiol. 143:797–807. 1996. View Article : Google Scholar
|
5.
|
Salvaggio J, Seabury J and Schoenhardt E:
New Orleans Asthma. V. Relationship between Charity Hospital
admission rates, semi-quantitative pollen and fungal spore counts,
and total particulate aerometric sampling data. J Allergy Clin
Immunol. 48:96–114. 1971. View Article : Google Scholar
|
6.
|
Newson R, Strachan D, Corden J and
Millington W: Fungal and other spore counts as predictors of
admissions for asthma in the Trent region. Occup Environ Med.
57:786–792. 2000. View Article : Google Scholar : PubMed/NCBI
|
7.
|
Denning DW, O’Driscoll BR, Hogaboam CM,
Bowyer P and Niven RM: The link between fungi and severe asthma: a
summary of the evidence. Eur Respir J. 27:615–626. 2006. View Article : Google Scholar : PubMed/NCBI
|
8.
|
Black PN, Udy AA and Brodie SM:
Sensitivity to fungal allergens is a risk factor for
life-threatening asthma. Allergy. 55:501–504. 2000. View Article : Google Scholar : PubMed/NCBI
|
9.
|
O’Driscoll RB, Hopkinson L and Denning DW:
Mold sensitization is common amongst patients with severe asthma
requiring multiple hospital admissions. BMC Pulm Med.
5:42005.PubMed/NCBI
|
10.
|
Neukirch C, Henry C, Leynaert B, Liard R,
Bousquet J and Neukirch F: Is sensitization to Alternaria
alternata a risk factor for severe asthma? A population-based
study. J Allergy Clin Immunol. 103:709–711. 1999.
|
11.
|
Zureik M, Neukirch C, Leynaert B, Liard R,
Bousquet J and Neukirch F; European Community Respiratory Health
Survey: Sensitisation to airborne moulds and severity of asthma:
cross sectional study from European Community respiratory health
survey. BMJ. 325:411–417. 2002. View Article : Google Scholar : PubMed/NCBI
|
12.
|
O’Hollaren MT, Yunginger JW, Offord KP,
Somers MJ, O’Connell EJ, Ballard DJ and Sachs MI: Exposure to an
aeroallergen as a possible precipitating factor in respiratory
arrest in young patients with asthma. N Engl J Med. 324:359–363.
1991.PubMed/NCBI
|
13.
|
Asthma Group of Respiratory Disease
Division of Chinese Medical Association: Guidelines for the
prevention and treatment of bronchial asthma. Chinese Journal of
Tuberculosis and Respiratory Diseases. 31:177–185. 2008.(In
Chinese).
|
14.
|
Kleyn JG, Johnson WM and Wetzler TF:
Microbial aerosols and actinomycetes in etiological considerations
of mushroom workers’ lungs. Appl Environ Microbiol. 41:1454–1460.
1981.PubMed/NCBI
|
15.
|
Zhai JH, Cui H, Chen ML, Xu XZ, Shun ZH,
Hu QX and Sun RQ: Analysis and identification of airborne fungus in
Beijing and Nanjing. China Public Health. 16:10262000.(In
Chinese).
|
16.
|
Matsuoka H, Niimi A, Matsumoto H, et al:
Specific IgE response to trichophyton and asthma severity. Chest.
135:898–903. 2009. View Article : Google Scholar : PubMed/NCBI
|
17.
|
Ward GW Jr, Karlsson G, Rose G and
Platts-Mills TA: Trichophyton asthma: sensitization of bronchi and
upper airways to dermatophyte antigen. Lancet. 1:859–862. 1989.
View Article : Google Scholar : PubMed/NCBI
|
18.
|
Riding DM, Denning DW, Francis HC and
Niven RM: The effect of itraconazole therapy in severe asthma
patients allergic to aspergillus: a retrospective audit. In:
Presented at the Advances against aspergillosis conference
(abstract 75); 2004, http://www.advancesagainstaspergillosis.org/pdfs/2004syllabus.pdfuri.
|
19.
|
Ward GW Jr, Woodfolk JA, Hayden ML,
Jackson S and Platts-Mills TA: Treatment of late-onset asthma with
fluconazole. J Allergy Clin Immunol. 104:541–546. 1999. View Article : Google Scholar : PubMed/NCBI
|
20.
|
Denning DW, O’Driscoll BR, Powell G, et
al: Randomized controlled trial of oral antifungal treatment for
severe asthma with fungal sensitization: The Fungal Asthma
Sensitization Trial (FAST) study. Am J Respir Crit Care Med.
179:11–18. 2009. View Article : Google Scholar : PubMed/NCBI
|